Cilostazol With Nimodipine to Improve Outcome After Aneurysmal Subarachnoid Hemorrhage

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

630

Participants

Timeline

Start Date

December 15, 2025

Primary Completion Date

December 14, 2029

Study Completion Date

December 14, 2029

Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
BIOLOGICAL

Cilostazol (Pletal®) 100 mg Tablets

100 mg orally or via feeding tube twice daily for 14 days, starting within 96 hours after aneurysmal subarachnoid hemorrhage onset. Tablets may be crushed for enteral administration.

DRUG

Placebo

Oral or enteral placebo, visually identical to cilostazol, twice daily for 14 days, starting within 96 hours after hemorrhage onset.

DRUG

Nimodipine group

Administered orally, enterally, or intravenously for 21 days as part of standard of care. Dose, route, and duration determined by treating physician according to clinical condition and guidelines.

All Listed Sponsors
lead

Centre Hospitalier St Anne

OTHER